Atlantic American Corporation Reports Second Quarter Results for 2024
Atlantic American (Nasdaq: AAME) reported a net loss of $0.7 million, or $(0.04) per diluted share, for Q2 2024, compared to a net income of $1.7 million in Q2 2023. The company's six-month net loss increased to $2.7 million in 2024 from $0.3 million in 2023. The losses were primarily due to unfavorable loss experience in both life and health operations and property and casualty operations. Operating income decreased by $2.8 million in Q2 and $5.7 million for the six-month period. Despite challenges, CEO Hilton H. Howell Jr. expressed optimism about recent product launches and the company's long-term strategy.
Atlantic American (Nasdaq: AAME) ha riportato una perdita netta di 0,7 milioni di dollari, ovvero $(0,04) per azione diluita, per il secondo trimestre del 2024, rispetto a un utile netto di 1,7 milioni di dollari nel secondo trimestre del 2023. La perdita netta semestrale della società è aumentata a 2,7 milioni di dollari nel 2024, rispetto a 0,3 milioni nel 2023. Le perdite sono state principalmente dovute a un andamento sfavorevole delle perdite sia nelle operazioni di vita e salute, sia in quelle di proprietà e danni. Il reddito operativo è diminuito di 2,8 milioni di dollari nel secondo trimestre e di 5,7 milioni di dollari nel periodo semestrale. Nonostante le difficoltà, il CEO Hilton H. Howell Jr. ha espresso ottimismo riguardo ai recenti lanci di prodotti e alla strategia a lungo termine della società.
Atlantic American (Nasdaq: AAME) reportó una pérdida neta de 0,7 millones de dólares, o $(0,04) por acción diluida, para el segundo trimestre de 2024, en comparación con una ganancia neta de 1,7 millones de dólares en el segundo trimestre de 2023. La pérdida neta de seis meses de la compañía aumentó a 2,7 millones de dólares en 2024 desde 0,3 millones en 2023. Las pérdidas se debieron principalmente a experiencias de pérdidas desfavorables tanto en las operaciones de vida y salud como en las de propiedad y accidentes. El ingreso operativo disminuyó en 2,8 millones de dólares en el segundo trimestre y en 5,7 millones de dólares durante el período de seis meses. A pesar de los desafíos, el CEO Hilton H. Howell Jr. expresó optimismo sobre los recientes lanzamientos de productos y la estrategia a largo plazo de la compañía.
애틀란틱 아메리칸 (Nasdaq: AAME)은 2024년 2분기에 70만 달러의 순손실, 즉 희석 주당 $(0.04)의 손실을 보고했으며, 이는 2023년 2분기의 순이익 170만 달러와 비교됩니다. 회사의 6개월 순손실은 2024년에 270만 달러로 증가했으며, 2023년에는 30만 달러였습니다. 손실의 주된 원인은 생명 및 건강 운영과 재산 및 상해 운영 모두에서 발생한 불리한 손실 경험 때문이었습니다. 운영 수익은 2분기 동안 280만 달러, 6개월 동안 570만 달러 감소했습니다. 어려움에도 불구하고 CEO 힐튼 H. 하웰 주니어는 최근 제품 출시와 회사의 장기 전략에 대한 낙관적인 의견을 표명했습니다.
Atlantic American (Nasdaq: AAME) a annoncé une perte nette de 0,7 million de dollars, soit $(0,04) par action diluée, pour le deuxième trimestre 2024, contre un bénéfice net de 1,7 million de dollars au deuxième trimestre 2023. La perte nette semestrielle de l'entreprise a augmenté à 2,7 millions de dollars en 2024, contre 0,3 million en 2023. Les pertes étaient principalement dues à une expérience de pertes défavorable tant dans les opérations de vie et de santé que dans les opérations de biens et de responsabilité. Le résultat d'exploitation a diminué de 2,8 millions de dollars au deuxième trimestre et de 5,7 millions de dollars pour la période semestrielle. Malgré les défis, le PDG Hilton H. Howell Jr. a exprimé son optimisme concernant les lancements récents de produits et la stratégie à long terme de l'entreprise.
Atlantic American (Nasdaq: AAME) berichtete von einem Nettoverlust von 0,7 Millionen Dollar, oder $(0,04) pro verwässerter Aktie, für das zweite Quartal 2024, verglichen mit einem Nettogewinn von 1,7 Millionen Dollar im zweiten Quartal 2023. Der Nettoverlust des Unternehmens über sechs Monate erhöhte sich 2024 auf 2,7 Millionen Dollar von 0,3 Millionen Dollar im Jahr 2023. Die Verluste waren hauptsächlich auf ungünstige Verlustentwicklung sowohl in den Lebens- und Gesundheitsoperationen als auch in den Sach- und Unfalloperationen zurückzuführen. Der operative Gewinn fiel im zweiten Quartal um 2,8 Millionen Dollar und über den Zeitraum von sechs Monaten um 5,7 Millionen Dollar. Trotz der Herausforderungen äußerte CEO Hilton H. Howell Jr. Optimismus über die kürzlich erfolgten Produkteinführungen und die langfristige Strategie des Unternehmens.
- Recent product launches in key states position the company for a strong sales season
- Property and casualty division demonstrates resilience in a softening market
- Strategic investments in technology and talent are expected to improve future performance
- Net loss of $0.7 million in Q2 2024 compared to net income of $1.7 million in Q2 2023
- Six-month net loss increased to $2.7 million in 2024 from $0.3 million in 2023
- Operating income decreased by $2.8 million in Q2 and $5.7 million for the six-month period
- Unfavorable loss experience in life and health operations, particularly in group life and Medicare supplement lines
- Increased frequency and severity of claims in the automobile liability line of business
Insights
Atlantic American 's Q2 2024 results reveal significant challenges. The company reported a
Key concerns include:
- Operating income decreased by
$2.8 million in Q2 and$5.7 million for H1 2024 - Increased incurred losses in group life and Medicare supplement lines
- Higher frequency and severity of claims in automobile liability
While management remains optimistic about recent product launches and strategic investments, these results suggest underlying operational issues that need addressing. Investors should closely monitor the company's ability to improve underwriting performance and navigate the softening market conditions.
The Q2 2024 results for Atlantic American highlight systemic challenges across multiple insurance lines. The unfavorable loss experience in both life & health and property & casualty segments points to potential issues in risk assessment and pricing strategies.
Of particular concern:
- Increased losses in Medicare supplement business, suggesting possible mispricing or demographic shifts
- Higher claims in automobile liability, indicating potential underwriting or risk selection issues
While management's focus on technology investments and new product launches is commendable, the immediate priority should be on reassessing risk models and improving underwriting discipline. The company's ability to adapt to these challenges during the upcoming annual enrollment period will be important for its near-term performance and long-term sustainability in a competitive insurance market.
ATLANTA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net loss of
Operating income decreased
Commenting on the results, Hilton H. Howell, Jr., Chairman, President and Chief Executive Officer, stated, “Although this year has presented challenges in our life and health operations, we believe our strategic investments in technology and talent will provide the foundation for future performance. We believe our recent product launches in several key states position us well for a strong sales season during the upcoming annual enrollment period. Additionally, our property and casualty division has demonstrated remarkable resilience in a softening market, consistently writing profitable business. We remain committed to our long-term strategy and are optimistic about the opportunities that lie ahead.”
Atlantic American Corporation is an insurance holding company involved through its subsidiary companies in specialty markets of the life, health, and property and casualty insurance industries. Its principal insurance subsidiaries are American Southern Insurance Company, American Safety Insurance Company, Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company.
Note regarding non-GAAP financial measure: Atlantic American Corporation presents its consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP). However, from time to time, the Company may present, in its public statements, press releases and filings with the Securities and Exchange Commission, non-GAAP financial measures such as operating income (loss). We define operating income (loss) as net income (loss) excluding: (i) income tax expense (benefit); (ii) realized investment (gains) losses, net; and (iii) unrealized (gains) losses on equity securities, net. Management believes operating income (loss) is a useful metric for investors, potential investors, securities analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as income tax expense (benefit), which is subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operating results (such as any realized and unrealized investment gains (losses), which are not a part of the Company’s primary operations and are, to a limited extent, subject to discretion in terms of timing of realization). The financial data attached includes a reconciliation of operating income (loss) to net income (loss), the most comparable GAAP financial measure. The Company’s definition of operating income (loss) may differ from similarly titled financial measures used by others. This non-GAAP financial measure should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.
Note regarding forward-looking statements: Except for historical information contained herein, this press release contains forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those indicated by such forward-looking statements due to a number of factors and risks, including the Company’s ability to remediate the identified material weakness in its internal control over financial reporting as described in the Company’s most recent Annual Report on Form 10-K and those other risks and uncertainties detailed in statements and reports that the Company files from time to time with the Securities and Exchange Commission.
For further information contact: | |
J. Ross Franklin | Hilton H. Howell, Jr. |
Chief Financial Officer | Chairman, President & CEO |
Atlantic American Corporation | Atlantic American Corporation |
404-266-5580 | 404-266-5505 |
Atlantic American Corporation | |||||||||||||||
Financial Data | |||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | ||||||||||||||
(Unaudited; In thousands, except per share data) | 2024 | 2023 | 2024 | 2023 | |||||||||||
Insurance premiums | |||||||||||||||
Life and health | $ | 27,449 | $ | 28,180 | $ | 54,123 | $ | 57,069 | |||||||
Property and casualty | 17,544 | 17,880 | 35,422 | 35,091 | |||||||||||
Insurance premiums, net | 44,993 | 46,060 | 89,545 | 92,160 | |||||||||||
Net investment income | 2,416 | 2,559 | 4,972 | 5,100 | |||||||||||
Realized investment gains, net | 13 | 70 | 13 | 70 | |||||||||||
Unrealized gains (losses) on equity securities, net | 243 | 494 | 129 | (1,881 | ) | ||||||||||
Other income | 3 | 5 | 6 | 8 | |||||||||||
Total revenue | 47,668 | 49,188 | 94,665 | 95,457 | |||||||||||
Insurance benefits and losses incurred | |||||||||||||||
Life and health | 17,579 | 15,817 | 36,691 | 33,617 | |||||||||||
Property and casualty | 14,228 | 13,548 | 27,041 | 26,208 | |||||||||||
Commissions and underwriting expenses | 11,584 | 12,848 | 24,250 | 25,766 | |||||||||||
Interest expense | 867 | 807 | 1,722 | 1,557 | |||||||||||
Other expense | 4,259 | 3,951 | 8,316 | 7,910 | |||||||||||
Total benefits and expenses | 48,517 | 46,971 | 98,020 | 95,058 | |||||||||||
Income (loss) before income taxes | (849 | ) | 2,217 | (3,355 | ) | 399 | |||||||||
Income tax expense (benefit) | (165 | ) | 473 | (673 | ) | 101 | |||||||||
Net income (loss) | $ | (684 | ) | $ | 1,744 | $ | (2,682 | ) | $ | 298 | |||||
Earnings (loss) per common share (basic & diluted) | $ | (0.04 | ) | $ | 0.08 | $ | (0.14 | ) | $ | - | |||||
Reconciliation of non-GAAP financial measure | |||||||||||||||
Net income (loss) | $ | (684 | ) | $ | 1,744 | $ | (2,682 | ) | $ | 298 | |||||
Income tax expense (benefit) | (165 | ) | 473 | (673 | ) | 101 | |||||||||
Realized investment gains, net | (13 | ) | (70 | ) | (13 | ) | (70 | ) | |||||||
Unrealized (gains) losses on equity securities, net | (243 | ) | (494 | ) | (129 | ) | 1,881 | ||||||||
Non-GAAP operating income (loss) | $ | (1,105 | ) | $ | 1,653 | $ | (3,497 | ) | $ | 2,210 | |||||
June 30, | December 31, | ||||||||||||||
Selected balance sheet data | 2024 | 2023 | |||||||||||||
Total cash and investments | $ | 256,525 | $ | 265,368 | |||||||||||
Insurance subsidiaries | 248,857 | 259,253 | |||||||||||||
Parent and other | 7,668 | 6,115 | |||||||||||||
Total assets | 386,007 | 381,265 | |||||||||||||
Insurance reserves and policyholder funds | 225,252 | 212,422 | |||||||||||||
Debt | 37,762 | 36,757 | |||||||||||||
Total shareholders' equity | 100,672 | 107,275 | |||||||||||||
Book value per common share | 4.67 | 4.99 | |||||||||||||
Statutory capital and surplus | |||||||||||||||
Life and health | 32,689 | 38,299 | |||||||||||||
Property and casualty | 51,967 | 51,774 | |||||||||||||
FAQ
What was Atlantic American 's (AAME) net loss for Q2 2024?
How did AAME's Q2 2024 results compare to Q2 2023?
What factors contributed to AAME's losses in Q2 2024?
How much did AAME's operating income decrease in Q2 2024?